Figures & data
Figure 1. (a) Solubility of curcumin in different oils; (b) Solubility of curcumin in surfactants.
Figure 2. Pseudoternary phase diagram for optimization of NE.
Table 1. NE formulations composition, physical stability and dispersion studies.
Figure 3. (a) The globule size distribution of NE-SB1; (b) Surface morphology of NE-SB1by TEM; (c) Surface topography of NE-SB1 by AFM.
Table 2. Parameters of selected NE formulations.
Figure 4. (a) Ex vivo release profile of CU in phosphate buffer (pH 6.8); (b) % FFA release profile with time.
Figure 5. Plasma concentration-time profile of curcumin after oral administration of NE-SB1 (50 mg/kg) to rats. Each data point represents the mean ± S.D. of three determinations.
Table 3. Pharmacokinetic parameters after oral administration of CU formulations to rats.
Figure 6. Anti-proliferative activity study of CU solution and NE-SB1 formulation.
